Dynamic contrast-enhanced MRI and sonography in patients receiving primary chemotherapy for breast cancer

Filippo Montemurro; Laura Martincich; Giovanni De Rosa; Stefano Cirillo; Vincenzo Marra; Nicoletta Biglia; Marco Gatti; Piero Sismondi; Massimo Aglietta; Daniele Regge

doi:10.1007/s00330-005-2656-6

Dynamic contrast-enhanced MRI and sonography in patients receiving primary chemotherapy for breast cancer

Filippo Montemurro, Laura Martincich, Giovanni De Rosa, Stefano Cirillo, Vincenzo Marra, Nicoletta Biglia, Marco Gatti, Piero Sismondi, Massimo Aglietta, Daniele Regge

Istituto Oncologico Candiolo

Research output: Contribution to journal › Article › peer-review

Abstract

We compared dynamic contrast-enhanced MRI (DCE-MRI) and sonography (US) for monitoring tumour size in 21 patients with breast cancer undergoing primary chemotherapy (PCT) followed by surgery. The correlation between DCE-MRI and US measurements of tumour size, defined as the product of the two major diameters, was 0.555 (P =0.009), 0.782 (P2, P2, P=0.009). After PCT, the median tumour size measured by the two techniques was similar (256 vs 289 mm² for DCE-MRI and US, respectively, P=0.859). The correlation with the histopathological major tumour diameter was 0.824 (P

Original language	English
Pages (from-to)	1224-1233
Number of pages	10
Journal	European Radiology
Volume	15
Issue number	6
DOIs	https://doi.org/10.1007/s00330-005-2656-6
Publication status	Published - Jun 2005

Keywords

Breast neoplasms
Magnetic resonance imaging
Primary chemotherapy
Sonography

ASJC Scopus subject areas

Radiology Nuclear Medicine and imaging
Radiological and Ultrasound Technology

Access to Document

10.1007/s00330-005-2656-6

Cite this

@article{62a02f74b338447e88803db4536bc2e8,

title = "Dynamic contrast-enhanced MRI and sonography in patients receiving primary chemotherapy for breast cancer",

abstract = "We compared dynamic contrast-enhanced MRI (DCE-MRI) and sonography (US) for monitoring tumour size in 21 patients with breast cancer undergoing primary chemotherapy (PCT) followed by surgery. The correlation between DCE-MRI and US measurements of tumour size, defined as the product of the two major diameters, was 0.555 (P =0.009), 0.782 (P2, P2, P=0.009). After PCT, the median tumour size measured by the two techniques was similar (256 vs 289 mm2 for DCE-MRI and US, respectively, P=0.859). The correlation with the histopathological major tumour diameter was 0.824 (P",

keywords = "Breast neoplasms, Magnetic resonance imaging, Primary chemotherapy, Sonography",

author = "Filippo Montemurro and Laura Martincich and {De Rosa}, Giovanni and Stefano Cirillo and Vincenzo Marra and Nicoletta Biglia and Marco Gatti and Piero Sismondi and Massimo Aglietta and Daniele Regge",

year = "2005",

month = jun,

doi = "10.1007/s00330-005-2656-6",

language = "English",

volume = "15",

pages = "1224--1233",

journal = "European Radiology",

issn = "0938-7994",

publisher = "Springer Verlag",

number = "6",

}

TY - JOUR

T1 - Dynamic contrast-enhanced MRI and sonography in patients receiving primary chemotherapy for breast cancer

AU - Montemurro, Filippo

AU - Martincich, Laura

AU - De Rosa, Giovanni

AU - Cirillo, Stefano

AU - Marra, Vincenzo

AU - Biglia, Nicoletta

AU - Gatti, Marco

AU - Sismondi, Piero

AU - Aglietta, Massimo

AU - Regge, Daniele

PY - 2005/6

Y1 - 2005/6

N2 - We compared dynamic contrast-enhanced MRI (DCE-MRI) and sonography (US) for monitoring tumour size in 21 patients with breast cancer undergoing primary chemotherapy (PCT) followed by surgery. The correlation between DCE-MRI and US measurements of tumour size, defined as the product of the two major diameters, was 0.555 (P =0.009), 0.782 (P2, P2, P=0.009). After PCT, the median tumour size measured by the two techniques was similar (256 vs 289 mm2 for DCE-MRI and US, respectively, P=0.859). The correlation with the histopathological major tumour diameter was 0.824 (P

AB - We compared dynamic contrast-enhanced MRI (DCE-MRI) and sonography (US) for monitoring tumour size in 21 patients with breast cancer undergoing primary chemotherapy (PCT) followed by surgery. The correlation between DCE-MRI and US measurements of tumour size, defined as the product of the two major diameters, was 0.555 (P =0.009), 0.782 (P2, P2, P=0.009). After PCT, the median tumour size measured by the two techniques was similar (256 vs 289 mm2 for DCE-MRI and US, respectively, P=0.859). The correlation with the histopathological major tumour diameter was 0.824 (P

KW - Breast neoplasms

KW - Magnetic resonance imaging

KW - Primary chemotherapy

KW - Sonography

UR - http://www.scopus.com/inward/record.url?scp=20344394943&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=20344394943&partnerID=8YFLogxK

U2 - 10.1007/s00330-005-2656-6

DO - 10.1007/s00330-005-2656-6

M3 - Article

C2 - 15906034

AN - SCOPUS:20344394943

VL - 15

SP - 1224

EP - 1233

JO - European Radiology

JF - European Radiology

SN - 0938-7994

IS - 6

ER -

Dynamic contrast-enhanced MRI and sonography in patients receiving primary chemotherapy for breast cancer

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this